Carleton Sage, Ph.D.
Vice President, Computational Sciences
Carleton Sage has 19 years of drug discovery experience in the biotech industry, most recently at Arena Pharmaceuticals where he was Research Fellow in Computational Systems. He developed and applied novel computational approaches to internal and partnered drug discovery and design projects. These projects delivered more than a dozen molecules into preclinical and clinical development in the areas of Metabolism, CNS, Inflammation and Cardiovascular disease. Prior to Arena, he was Group Leader of Computational Sciences, at Lion Bioscience where he led teams supporting drug discovery projects and developing novel approaches to predicting ADME properties of molecules. Prior to Lion, he was the 5th employee at MetaXen where he ran the IT department, provided computational support to drug discovery projects and contributed to the development of novel algorithms for the prediction of ADME properties. Carleton trained as a post-doctoral fellow at the University of California, San Francisco, and has a Ph.D. in Biochemistry and Molecular Biology from the University of California, Santa Barbara.